2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $13.53 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.